Earnings ·
Lifeloc Technologies reported second quarter 2026 financial results showing net revenue of $2.445 million, a 10%…
LCTCLifeloc Technologies, Inc
Lifeloc Technologies reported second quarter 2026 financial results showing net revenue of $2.445 million, a 10% increase from the prior year period. The company posted a net loss of $134 thousand, or $0.05 per diluted share, compared to a net loss of $394 thousand in Q2 2025. Gross margin improved to 45% from 42%, driven by price increases and favorable product mix. The company also closed on a $500,000 related-party loan at 10.5% interest secured by all assets. Lifeloc Technologies is a U.S. manufacturer of evidential breath alcohol testers and drug detection devices.